Close Menu

NEW YORK (GenomeWeb) – CareDx said today that it expects to report fourth quarter revenues of $12.3 million to $12.5 million, an increase of 13 percent to 15 percent over Q4 2016 revenues of $10.9 million.

Testing revenues for the quarter are expected to be $8.4 million to $8.6 million compared with $7.4 million in the same period in 2016, and product revenues are expected to be $3.7 million compared to $3.5 million in Q4 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.